Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine for Low SVCF in Preterm Infants
NCT01605279Phase 2Completed
- Start
- Sep 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing Dobutamine with Placebo (2 arms). Primary endpoint: Low Superior Vena Cava Flow prevalence. Started Sep 2010; status: completed.
02
Drugs
dobutamine
Beyond the preview
Go deeper on NCT01605279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01605279.